Can a simple survey transform heart failure treatment?
NCT ID NCT04164004
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether routinely asking heart failure patients a 12-question survey about their symptoms and quality of life during clinic visits leads to better care. Over 1,200 participants were randomly assigned to start the survey right away or after a one-year delay. Researchers compared health status scores and treatment rates between the two groups to see if the survey helped doctors make more informed decisions.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could show that regularly asking patients about their symptoms and quality of life helps doctors make better treatment decisions for heart failure.
- What could go wrong
- This is an observational study focused on measuring outcomes, not testing a new treatment. The results may not change standard care or directly improve patient health.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
1,249 people
The number who actually took part.
- Started
-
Aug 2021
- Finished
-
Nov 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Stanford Heart Failure clinic visit during enrollment period Exclusion Criteria: * Seen in amyloid clinic
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Heart failure are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Stanford Hospital & Clinics
Stanford, California, 94305, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which SGLT2 inhibitor wins? trial pits empagliflozin against dapagliflozin
- Can daily mindful breathing ease heart failure symptoms?
- Can a smartphone app keep heart failure patients out of the hospital?
- Can better training get doctors to talk about what matters most to dying veterans?
- Can AI read heart ultrasounds as well as trained sonographers?
- Can modern heart failure drugs reverse damage in three months?